drugset / Trial / NCT06907849
124I-Evuzamitide PET/CT Imaging In Patients With Lumbar Spinal Stenosis and Carpal Tunnel Syndrome
Phase 2
Enrolling by invitation
40 enrolled
University of Tennessee Graduate School of Medicine
Attralus, Inc. · collab
NaSingle-groupOpen-labelDiagnostic
Summary
This clinical trial will use the amyloid-binding radiotracer, 124I-evuzamitide, to potentially detect amyloid, in the heart and elsewhere, in patients who have a history of lumbar spinal stenosis and/or carpal tunnel syndrome.
Timeline
- Start
- 2025-05
- Primary completion
- 2027-03
- Completion
- 2027-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 124I-evuzamitide | Peptide | 1 mg | Intravenous |